Annual Operating Expenses
$33.92 M
+$11.20 M+49.31%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total operating expenses is $33.92 million, with the most recent change of +$11.20 million (+49.31%) on December 31, 2023.
- During the last 3 years, CTNM annual operating expenses has risen by +$5.28 million (+18.42%).
- CTNM annual operating expenses is now at all-time high.
Performance
CTNM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$12.97 M
+$2.03 M+18.55%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total operating expenses is $12.97 million, with the most recent change of +$2.03 million (+18.55%) on September 30, 2024.
- Over the past year, CTNM quarterly operating expenses has increased by +$3.30 million (+34.08%).
- CTNM quarterly operating expenses is now at all-time high.
Performance
CTNM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CTNM Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.3% | +34.1% |
| 3 y3 years | +18.4% | +138.1% |
| 5 y5 years | +18.4% | +138.1% |
CTNM Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.3% | at high | +153.7% |
| 5 y | 5-year | at high | +49.3% | at high | +153.7% |
| alltime | all time | at high | +49.3% | at high | +153.7% |
Contineum Therapeutics Class A Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.97 M(+18.5%) |
| Jun 2024 | - | $10.94 M(+10.2%) |
| Mar 2024 | - | $9.93 M(+2.6%) |
| Dec 2023 | $33.92 M | $9.68 M(+19.9%) |
| Sep 2023 | - | $8.07 M(-27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $11.06 M(+116.3%) |
| Mar 2023 | - | $5.12 M(-6.1%) |
| Dec 2022 | $22.72 M(-20.7%) | - |
| Dec 2022 | - | $5.45 M |
| Dec 2021 | $28.65 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total operating expenses?
- What is the all time high annual operating expenses for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual operating expenses year-on-year change?
- What is Contineum Therapeutics Class A quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly operating expenses year-on-year change?
What is Contineum Therapeutics Class A annual total operating expenses?
The current annual operating expenses of CTNM is $33.92 M
What is the all time high annual operating expenses for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total operating expenses is $33.92 M
What is Contineum Therapeutics Class A annual operating expenses year-on-year change?
Over the past year, CTNM annual total operating expenses has changed by +$11.20 M (+49.31%)
What is Contineum Therapeutics Class A quarterly total operating expenses?
The current quarterly operating expenses of CTNM is $12.97 M
What is the all time high quarterly operating expenses for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total operating expenses is $12.97 M
What is Contineum Therapeutics Class A quarterly operating expenses year-on-year change?
Over the past year, CTNM quarterly total operating expenses has changed by +$3.30 M (+34.08%)